{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:10:10Z","timestamp":1787069410791,"version":"build-2736575974"},"reference-count":42,"publisher":"IMR Press","issue":"4","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shenzhen Foundation of Science and Technology","award":["JCYJ20240813153002004"],"award-info":[{"award-number":["JCYJ20240813153002004"]}]},{"name":"Shenzhen Foundation of Science and Technology","award":["JCYJ20250604191024032"],"award-info":[{"award-number":["JCYJ20250604191024032"]}]},{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2025A1515012512"],"award-info":[{"award-number":["2025A1515012512"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shenzhen Longhua District Healthcare Institutions Scientific Research Project","award":["2022041"],"award-info":[{"award-number":["2022041"]}]},{"name":"Key Medical Discipline Construction Fund of Shenzhen Longhua District"},{"name":"Guangdong Yiyang Healthcare Charity Foundation","award":["JZ2025107"],"award-info":[{"award-number":["JZ2025107"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Membranous nephropathy (MN) is one of the most common forms of primary glomerulonephritis worldwide and is closely associated with immune dysregulation. Increasing evidence suggests that the gut microbiota plays a critical role in regulating renal disease through the gut\u2013renal axis. However, the use of metagenomic sequencing to analyze changes in the gut microbiota in patients with MN has not yet been reported. Methods: This study employed a metagenomic approach to comprehensively analyze the gut microbiota in patients with MN (n = 10) and normal controls (NCs; n = 10). Shotgun metagenomic sequencing was performed on fecal samples. Microbial diversity, taxonomic composition, and functional pathways were assessed, followed by Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. In addition, correlations between gut microbial characteristics and clinical indicators were also evaluated. Results: The gut microbial community in the MN group showed distinct differences from the control group, particularly with an increased abundance in phylum: Proteobacteria, Firmicutes_C, and Cyanobacteria; the genera Dialister, Selenomonadales, Clostridium, Bacillus, Megamonas, Romboutsia, and Inesitibacter; the species Bilophila_wadsworthia, Enterococcus_C, Megamonas funiformis, and Clostridium_perfringens. Furthermore, Bacillus_A showed a significant positive correlation with both serum creatinine and the protein-to-creatinine ratio. Conversely, higher levels of Victivallis were associated with lower blood urea nitrogen, while increased Fusicatenibacter was correlated with lower phospholipase A2 receptor levels. KEGG analysis indicated that the MN gut microbiota was enriched for pathways related to tryptophan metabolism, oxidative phosphorylation, and pathogenic Escherichia coli infection. Additionally, receiver operating characteristic analysis revealed that a four-genus model comprising enriched Dialister, Enterococcus_C, and Clostridium_P, and reduced Fusicatenibacter yielded an area under the curve of 0.90 \u00b1 0.12, suggesting promising discriminatory potential that warrants further validation. Conclusion: These findings demonstrate alterations in the composition and functional potential of the gut microbiota in patients with MN compared with the control group. Given the cross-sectional design of this study, these observations should be interpreted as associative, and further studies are required to validate these findings and explore any associated biological relevance.<\/jats:p>","DOI":"10.31083\/fbl48982","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:29:27Z","timestamp":1777454967000},"source":"Crossref","is-referenced-by-count":0,"title":["Metagenomic Analysis Reveals Gut Microbiota Features in Membranous Nephropathy"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8464-7563","authenticated-orcid":true,"given":"Yanmei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nephrology, Shenzhen Longhua District Central Hospital, The Affiliated Longhua Hospital of Shenzhen University, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic Kidney Disease, 518110 Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3225-801X","authenticated-orcid":true,"given":"Hanchao","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shenzhen Longhua District Central Hospital, The Affiliated Longhua Hospital of Shenzhen University, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic Kidney Disease, 518110 Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1269-8229","authenticated-orcid":true,"given":"Zhennan","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Affiliated Hospital of Jinan University, 510630 Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2013-5311","authenticated-orcid":true,"given":"Zixi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shenzhen Longhua District Central Hospital, The Affiliated Longhua Hospital of Shenzhen University, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic Kidney Disease, 518110 Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0300-2733","authenticated-orcid":true,"given":"Zhuoheng","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shenzhen Longhua District Central Hospital, The Affiliated Longhua Hospital of Shenzhen University, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic Kidney Disease, 518110 Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8398-091X","authenticated-orcid":true,"given":"Wenjun","family":"Xiong","sequence":"additional","affiliation":[{"name":"Clinical Medical Research Center, The Second Clinical Medical College of Jinan University, Shenzhen People\u2019s Hospital, 518020 Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6840-9158","authenticated-orcid":true,"given":"Yong","family":"Dai","sequence":"additional","affiliation":[{"name":"Future Medicine Center, Shenzhen University of Advanced Technology, 518107 Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8570-4274","authenticated-orcid":true,"given":"Weilong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shenzhen Longhua District Central Hospital, The Affiliated Longhua Hospital of Shenzhen University, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic Kidney Disease, 518110 Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8751-9089","authenticated-orcid":true,"given":"Shaodong","family":"Luan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shenzhen Longhua District Central Hospital, The Affiliated Longhua Hospital of Shenzhen University, Shenzhen Longhua District Key Laboratory for Diagnosis and Treatment of Chronic Kidney Disease, 518110 Shenzhen, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Stamellou E, Seikrit C, Tang SCW, Boor P, Tesa\u0159 V, Floege J, et al. IgA nephropathy. Nature Reviews Disease Primers. 2023; 9: 68.","DOI":"10.1038\/s41572-023-00483-w"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Ronco P, Beck L, Debiec H, Fervenza FC, Hou FF, Jha V, et al. Membranous nephropathy. Nature Reviews. Disease Primers. 2021; 7: 69.","DOI":"10.1038\/s41572-021-00303-z"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Xiao M, Chi X, Zhu X, Xu Z, Zou Y, Peng Y, et al. Proteomic analysis of laser captured tubular tissues reveals complement activation and mitochondrial dysfunction in autoimmune related kidney diseases. Scientific Reports. 2024; 14: 19311.","DOI":"10.1038\/s41598-024-70209-9"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Li C, Wen Q, Zhang Y, Wu J. Causal associations between environmental factors and risk of IgA nephropathy and membranous nephropathy: a bidirectional Mendelian randomization and mediation analysis. Renal Failure. 2025; 47: 2486620.","DOI":"10.1080\/0886022X.2025.2486620"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Gupta S, K\u00f6ttgen A, Hoxha E, Brenchley P, Bockenhauer D, Stanescu HC, et al. Genetics of membranous nephropathy. Nephrology Dialysis Transplantation. 2018; 33: 1493\u20131502.","DOI":"10.1093\/ndt\/gfx296"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Duan X, Lv X, Wang X, Zhang Y, Hu Y, Li H, et al. Impact of immune cell metabolism on membranous nephropathy and prospective therapy. Communications Biology. 2025; 8: 405.","DOI":"10.1038\/s42003-025-07816-3"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Tie X, Chen Z, Yao S, Wu B, Yan B, Zhai H, et al. Immune Imbalance in Primary Membranous Nephropathy at Single-cell Resolution. Frontiers in Bioscience (Landmark Edition). 2025; 30: 36332.","DOI":"10.31083\/FBL36332"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Wu X, Xia Y, He F, Zhu C, Ren W. Intestinal mycobiota in health and diseases: from a disrupted equilibrium to clinical opportunities. Microbiome. 2021; 9: 60.","DOI":"10.1186\/s40168-021-01024-x"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Jiang Y, Xu H, Zhang W, Jin S, Piao H, Yu J, et al. Advances in the Study of Intestinal Microbiota and Neuropathic Pain. Frontiers in Bioscience (Landmark Edition). 2025; 30: 43051.","DOI":"10.31083\/FBL43051"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Boulang\u00e9 CL, Neves AL, Chilloux J, Nicholson JK, Dumas ME. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Medicine. 2016; 8: 42.","DOI":"10.1186\/s13073-016-0303-2"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Chang WL, Chen YE, Tseng HT, Cheng CF, Wu JH, Hou YC. Gut Microbiota in Patients with Prediabetes. Nutrients. 2024; 16: 1105.","DOI":"10.3390\/nu16081105"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Du Y, Li Y, Xu X, Li R, Zhang M, Cui Y, et al. Probiotics for constipation and gut microbiota in Parkinson\u2019s disease. Parkinsonism & Related Disorders. 2022; 103: 92\u201397.","DOI":"10.1016\/j.parkreldis.2022.08.022"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Ma C, He J, Lai L, Chen Y, Xue W, Chen J, et al. Intestinal microbiome and metabolome analyses reveal metabolic disorders in the early stage of renal transplantation. Molecular Omics. 2021; 17: 985\u2013996.","DOI":"10.1039\/d1mo00279a"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Pereira IM, Pereira M, Lopes JA, Gameiro J. The gut microbiome as a potential therapeutic target in IgA nephropathy. Nephrology, Dialysis, Transplantation. 2025; 40: 641\u2013650.","DOI":"10.1093\/ndt\/gfae274"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Zhang R, Tang Y, Feng X, Lu X, Zhao M, Jin J, et al. Targeted modulation of intestinal barrier and mucosal immune-related microbiota attenuates IgA nephropathy progression. Gut Microbes. 2025; 17: 2458184.","DOI":"10.1080\/19490976.2025.2458184"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Wu H, Tang D, Yun M, Liu H, Huang S, Yun C, et al. Metabolic Dysfunctions of Intestinal Fatty Acids and Tryptophan Reveal Immuno-Inflammatory Response Activation in IgA Nephropathy. Frontiers in Medicine. 2022; 9: 811526.","DOI":"10.3389\/fmed.2022.811526"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Qing J, Li C, Jiao N. Deciphering the causal link between gut microbiota and membranous nephropathy: insights into potential inflammatory mechanisms. Renal Failure. 2025; 47: 2476053.","DOI":"10.1080\/0886022X.2025.2476053"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Miao H, Zhang Y, Yu X, Zou L, Zhao Y. Membranous nephropathy: systems biology-based novel mechanism and traditional chinese medicine therapy. Frontiers in Pharmacology. 2022; 13: 969930. https:\/\/www.x-mol.com\/paperRedirect\/1569734644155518976.","DOI":"10.3389\/fphar.2022.969930"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Li J, Shen Y, Yan K, Wang S, Jiao J, Chi H, et al. The compositional and functional imbalance of the gut microbiota in CKD linked to disease patterns. Journal of Translational Medicine. 2024; 22: 773.","DOI":"10.1186\/s12967-024-05578-w"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Baev V. Bioinformatics Research in Bacterial Genomics and Metagenomics. Current Issues in Molecular Biology. 2025; 47: 258.","DOI":"10.3390\/cimb47040258"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Mudrik-Zohar H, Carasso S, Gefen T, Zalmanovich A, Katzir M, Cohen Y, et al. Microbiome Characterization of Infected Diabetic Foot Ulcers in Association With Clinical Outcomes: Traditional Cultures Versus Molecular Sequencing Methods. Frontiers in Cellular and Infection Microbiology. 2022; 12: 836699.","DOI":"10.3389\/fcimb.2022.836699"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nature Reviews. Immunology. 2016; 16: 341\u2013352.","DOI":"10.1038\/nri.2016.42"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012; 486: 222\u2013227.","DOI":"10.1038\/nature11053"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Li M, Wei L, Sun J, Zhu Q, Yang H, Zhang Y, et al. Association of gut microbiota with idiopathic membranous nephropathy. BMC Nephrology. 2022; 23: 164.","DOI":"10.1186\/s12882-022-02797-5"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Dong R, Bai M, Zhao J, Wang D, Ning X, Sun S. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy. Frontiers in Cellular and Infection Microbiology. 2020; 10: 557368.","DOI":"10.3389\/fcimb.2020.557368"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Gao H, Bai H, Su Y, Gao Y, Fang H, Li D, et al. Fecal microbiota transplantation from Helicobacter pylori carriers following bismuth quadruple therapy exacerbates alcohol-related liver disease in mice via LPS-induced activation of hepatic TLR4\/NF-\u03baB\/NLRP3 signaling. Journal of Translational Medicine. 2025; 23: 627.","DOI":"10.1186\/s12967-025-06573-5"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Strakova N, Korena K, Karpiskova R. Klebsiella pneumoniae producing bacterial toxin colibactin as a risk of colorectal cancer development - A systematic review. Toxicon. 2021; 197: 126\u2013135.","DOI":"10.1016\/j.toxicon.2021.04.007"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Zhao J, Bai M, Ning X, Qin Y, Wang Y, Yu Z, et al. Expansion of Escherichia-Shigella in Gut Is Associated with the Onset and Response to Immunosuppressive Therapy of IgA Nephropathy. Journal of the American Society of Nephrology. 2022; 33: 2276\u20132292.","DOI":"10.1681\/ASN.2022020189"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Han S, Chen M, Cheng P, Zhang Z, Lu Y, Xu Y, et al. A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals. Frontiers in Endocrinology. 2022; 13: 1018093.","DOI":"10.3389\/fendo.2022.1018093"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Talukdar PK, Banawas S, Sarker MR. Clostridium perfringens. Trends in Microbiology. 2025; 33: 130\u2013131.","DOI":"10.1016\/j.tim.2024.09.009"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Maharshak N, Huh EY, Paiboonrungruang C, Shanahan M, Thurlow L, Herzog J, et al. Enterococcus faecalis Gelatinase Mediates Intestinal Permeability via Protease-Activated Receptor 2. Infection and Immunity. 2015; 83: 2762\u20132770.","DOI":"10.1128\/IAI.00425-15"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Li M, Wei Y, Cai M, Gu R, Pan X, Du J. Perilla peptides delay the progression of kidney disease by improving kidney apoptotic injury and oxidative stress and maintaining intestinal barrier function. Food Bioscience. 2021; 43: 101333.","DOI":"10.1016\/j.fbio.2021.101333"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Gao J, Xu K, Liu H, Liu G, Bai M, Peng C, et al. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. Frontiers in Cellular and Infection Microbiology. 2018; 8: 13.","DOI":"10.3389\/fcimb.2018.00013"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Miao H, Wang YN, Yu XY, Zou L, Guo Y, Su W, et al. Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites. British Journal of Pharmacology. 2024; 181: 162\u2013179.","DOI":"10.1111\/bph.16219"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Yang J, Wang Q, Wang Z, Zhang Y, Liu Q, Yang D. Edwardsiella piscicida infection-induced tryptophan-kynurenine metabolic pathway impairs Th17 cells to drive intestinal inflammation in teleost. Fish & Shellfish Immunology. 2025; 163: 110425.","DOI":"10.1016\/j.fsi.2025.110425"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Aoki K, Teshima Y, Kondo H, Saito S, Fukui A, Fukunaga N, et al. Role of Indoxyl Sulfate as a Predisposing Factor for Atrial Fibrillation in Renal Dysfunction. Journal of the American Heart Association. 2015; 4: e002023.","DOI":"10.1161\/JAHA.115.002023"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Ribeiro A, Liu F, Srebrzynski M, Rother S, Adamowicz K, Wadowska M, et al. Uremic Toxin Indoxyl Sulfate Promotes Macrophage-Associated Low-Grade Inflammation and Epithelial Cell Senescence. International Journal of Molecular Sciences. 2023; 24: 8031.","DOI":"10.3390\/ijms24098031"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Sokol H, Pigneur B, Watterlot L, Lakhdari O, Berm\u00fadez-Humar\u00e1n LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proceedings of the National Academy of Sciences. 2008; 105: 16731\u201316736.","DOI":"10.1073\/pnas.0804812105"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Mohebali N, Weigel M, Hain T, S\u00fctel M, Bull J, Kreikemeyer B, et al. Faecalibacterium prausnitzii, Bacteroides faecis and Roseburia intestinalis attenuate clinical symptoms of experimental colitis by regulating Treg\/Th17 cell balance and intestinal barrier integrity. Biomedicine & Pharmacotherapy. 2023; 167: 115568.","DOI":"10.1016\/j.biopha.2023.115568"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Wallimann A, Magrath W, Thompson K, Moriarty T, Richards RG, Akdis CA, et al. Gut microbial-derived short-chain fatty acids and bone: a potential role in fracture healing. European Cells & Materials. 2021; 41: 454\u2013470.","DOI":"10.22203\/eCM.v041a29"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Fox D, Mathur A, Xue Y, Liu Y, Tan WH, Feng S, et al. Bacillus cereus non-haemolytic enterotoxin activates the NLRP3 inflammasome. Nature Communications. 2020; 11: 760.","DOI":"10.1038\/s41467-020-14534-3"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Miyata J, Tasaka S, Miyazaki M, Yoshida S, Naoki K, Sayama K, et al. Bacillus cereus necrotizing pneumonia in a patient with nephrotic syndrome. Internal Medicine. 2013; 52: 101\u2013104.","DOI":"10.2169\/internalmedicine.52.7282"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/4\/10.31083\/FBL48982","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:30:32Z","timestamp":1777455032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/4\/10.31083\/FBL48982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02090-3"],"URL":"https:\/\/doi.org\/10.31083\/fbl48982","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"48982"}}